Literature DB >> 8137168

Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study.

H Hondo1, Y Yonezawa, T Nakahara, K Nakamura, M Hirano, H Uchimura, N Tashiro.   

Abstract

The effect of phencyclidine (PCP) on the extracellular dopamine levels in the rat prefrontal cortex was investigated using an in vivo brain dialysis technique. PCP increased extracellular dopamine levels in the prefrontal cortex of freely-moving rats after the systemic (7.5 mg/kg i.p.) or the local injection (100 microM and 500 microM). The local injection of MK-801, which is a more selective and potent NMDA receptor antagonist than PCP also increased the extracellular dopamine levels (from 10 microM to 100 microM). These results suggest that part of the effect of PCP is attributable to its antagonist effect on the NMDA receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8137168     DOI: 10.1016/0006-8993(94)91558-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  28 in total

1.  Effects of phencyclidine (PCP) and MK 801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, alpha(1)- and 5-HT(2A)-receptors.

Authors:  Claude Sebban; Brigitte Tesolin-Decros; Jorge Ciprian-Ollivier; Laurent Perret; Michael Spedding
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

2.  Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats.

Authors:  Nurith Amitai; Athina Markou
Journal:  Eur J Pharmacol       Date:  2010-04-02       Impact factor: 4.432

3.  When administered into the nucleus accumbens core or shell, the NMDA receptor antagonist AP-5 reinstates cocaine-seeking behavior in the rat.

Authors:  Katie R Famous; Heath D Schmidt; R Christopher Pierce
Journal:  Neurosci Lett       Date:  2007-05-03       Impact factor: 3.046

4.  Amphetamine stimulates movement through thalamocortical glutamate release.

Authors:  Omar S Mabrouk; Daniel Z Semaan; Sarah Mikelman; Margaret E Gnegy; Robert T Kennedy
Journal:  J Neurochem       Date:  2013-08-19       Impact factor: 5.372

5.  MK-801-induced behavioural sensitisation alters dopamine release and turnover in rat prefrontal cortex.

Authors:  Xiaoying Cui; Emilia Lefevre; Karly M Turner; Carlos M Coelho; Suzy Alexander; Thomas H J Burne; Darryl W Eyles
Journal:  Psychopharmacology (Berl)       Date:  2014-07-29       Impact factor: 4.530

6.  Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966.

Authors:  J D Jentsch; J D Elsworth; D E Redmond; R H Roth
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

7.  Effect of clozapine on locomotor activity and anxiety-related behavior in the neonatal mice administered MK-801.

Authors:  Neslihan Pınar; Kubra Akillioglu; Fatih Sefil; Harun Alp; Mustafa Sagir; Ahmet Acet
Journal:  Bosn J Basic Med Sci       Date:  2015-08-11       Impact factor: 3.363

Review 8.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

Review 9.  The potential role of lamotrigine in schizophrenia.

Authors:  Charles H Large; Elizabeth L Webster; Donald C Goff
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

10.  Effects of Ketamine and Ketamine Metabolites on Evoked Striatal Dopamine Release, Dopamine Receptors, and Monoamine Transporters.

Authors:  Adem Can; Panos Zanos; Ruin Moaddel; Hye Jin Kang; Katinia S S Dossou; Irving W Wainer; Joseph F Cheer; Douglas O Frost; Xi-Ping Huang; Todd D Gould
Journal:  J Pharmacol Exp Ther       Date:  2016-07-28       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.